Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jul;13(18):e2400388.
doi: 10.1002/adhm.202400388. Epub 2024 Mar 22.

Precision Culture Scaling to Establish High-Throughput Vasculogenesis Models

Affiliations

Precision Culture Scaling to Establish High-Throughput Vasculogenesis Models

Nicholas R Dennison et al. Adv Healthc Mater. 2024 Jul.

Abstract

Hydrogel-based 3D cell cultures can recapitulate (patho)physiological phenomena ex vivo. However, due to their complex multifactorial regulation, adapting these tissue and disease models for high-throughput screening workflows remains challenging. In this study, a new precision culture scaling (PCS-X) methodology combines statistical techniques (design of experiment and multiple linear regression) with automated, parallelized experiments and analyses to customize hydrogel-based vasculogenesis cultures using human umbilical vein endothelial cells and retinal microvascular endothelial cells. Variations of cell density, growth factor supplementation, and media composition are systematically explored to induce vasculogenesis in endothelial mono- and cocultures with mesenchymal stromal cells or retinal microvascular pericytes in 384-well plate formats. The developed cultures are shown to respond to vasculogenesis inhibitors in a compound- and dose-dependent manner, demonstrating the scope and power of PCS-X in creating parallelized tissue and disease models for drug discovery and individualized therapies.

Keywords: cell‐instructive hydrogels; design of experiments; high‐throughput screening; in vitro tissue and disease models; multiple linear regression; vasculogenesis.

PubMed Disclaimer

References

    1. J. L. Horning, S. K. Sahoo, S. Vijayaraghavalu, S. Dimitrijevic, J. K. Vasir, T. K. Jain, A. K. Panda, V. Labhasetwar, Mol. Pharmaceutics 2008, 5, 849.
    1. M. Potente, H. Gerhardt, P. Carmeliet, Cell 2011, 146, 873.
    1. H. Ragelle, A. Goncalves, S. Kustermann, D. A. Antonetti, A. Jayagopal, J. Ocul. Pharmacol. Ther. 2020, 36, 30.
    1. R. P. M. Dings, X. Chen, D. M. E. I. Hellebrekers, L. I. van Eijk, Y. Zhang, T. R. Hoye, A. W. Griffioen, K. H. Mayo, J. Natl. Cancer Inst. 2006, 98, 932.
    1. D. A. MacDonald, J. Martin, K. K. Muthusamy, J. K. Luo, E. Pyles, A. Rafique, T. Huang, T. Potocky, Y. Liu, J. Cao, et al., Angiogenesis 2016, 19, 389.

MeSH terms

LinkOut - more resources